Evolent Health (EVH) Invested Capital (2013 - 2026)

Evolent Health's Invested Capital history runs 14 years deep, the most recent figure standing at $396.4 million for Q1 2026.

• In Q1 2026, Invested Capital fell 64.2% year-over-year to $396.4 million; the TTM figure through Mar 2026 stood at $396.4 million (down 64.2% YoY), while the FY2025 annual figure was $415.2 million, down 64.6% from the prior year.
• Invested Capital was $396.4 million for Q1 2026 at Evolent Health, down from $415.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.2 billion in Q4 2024 to a low of $396.4 million in Q1 2026.
• Historically, Invested Capital has averaged $909.8 million across 5 years, with a median of $1.0 billion in 2024.
• The sharpest annual moves came in 2023 and 2025: Invested Capital jumped 83.53% in 2023, then slumped 64.6% in 2025.
• A 5-year view of Invested Capital shows it stood at $859.4 million in 2022, then increased by 24.24% to $1.1 billion in 2023, then grew by 9.84% to $1.2 billion in 2024, then plunged by 64.6% to $415.2 million in 2025, then dropped by 4.53% to $396.4 million in 2026.
• The last three Invested Capital figures came in at $396.4 million (Q1 2026), $415.2 million (Q4 2025), and $847.4 million (Q3 2025), per Business Quant data.